The Centers for Disease Control and Prevention (CDC) issued a health advisory today to share information and notify clinicians, public health authorities, and the public about—
- Identification of locally acquired malaria cases (P. vivax) in two U.S. states (Florida [4] and Texas [1]) within the last 2 months,
- Concern for a potential rise in imported malaria cases associated with increased international travel in summer 2023, and
- Need to plan for rapid access to IV artesunate, which is the first-line treatment for severe malaria in the United States.
